CA3121444A1 - Therapeutic agent of peripheral blood flow disorder - Google Patents
Therapeutic agent of peripheral blood flow disorder Download PDFInfo
- Publication number
- CA3121444A1 CA3121444A1 CA3121444A CA3121444A CA3121444A1 CA 3121444 A1 CA3121444 A1 CA 3121444A1 CA 3121444 A CA3121444 A CA 3121444A CA 3121444 A CA3121444 A CA 3121444A CA 3121444 A1 CA3121444 A1 CA 3121444A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- cell
- muse
- blood flow
- cell product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-225295 | 2018-11-30 | ||
| JP2018225295 | 2018-11-30 | ||
| PCT/JP2019/046847 WO2020111249A1 (ja) | 2018-11-30 | 2019-11-29 | 末梢血流障害の治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3121444A1 true CA3121444A1 (en) | 2020-06-04 |
Family
ID=70853028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3121444A Pending CA3121444A1 (en) | 2018-11-30 | 2019-11-29 | Therapeutic agent of peripheral blood flow disorder |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12611430B2 (https=) |
| EP (1) | EP3888751B1 (https=) |
| JP (1) | JP7473207B2 (https=) |
| KR (1) | KR102901451B1 (https=) |
| CN (1) | CN113195054A (https=) |
| AU (1) | AU2019388016B2 (https=) |
| CA (1) | CA3121444A1 (https=) |
| SG (1) | SG11202105686UA (https=) |
| WO (1) | WO2020111249A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9550975B2 (en) | 2009-07-15 | 2017-01-24 | Mari Dezawa | SSEA-3 pluripotent stem cell isolated from body tissue |
| WO2012024296A1 (en) * | 2010-08-20 | 2012-02-23 | University Of Miami | Arterial repair with cultured bone marrow cells and whole bone marrow |
| CN102641297B (zh) * | 2011-02-21 | 2016-02-24 | 杨子江 | 治疗外周动脉粥样硬化引起的缺血性疾病的制剂及其制备方法 |
| EP3492091B1 (en) | 2016-07-29 | 2021-07-14 | Tohoku University | "muse" cells as prophylactic or therapeutic agent for aneurysm |
-
2019
- 2019-11-29 JP JP2020557865A patent/JP7473207B2/ja active Active
- 2019-11-29 KR KR1020217018397A patent/KR102901451B1/ko active Active
- 2019-11-29 CA CA3121444A patent/CA3121444A1/en active Pending
- 2019-11-29 WO PCT/JP2019/046847 patent/WO2020111249A1/ja not_active Ceased
- 2019-11-29 US US17/298,367 patent/US12611430B2/en active Active
- 2019-11-29 SG SG11202105686UA patent/SG11202105686UA/en unknown
- 2019-11-29 AU AU2019388016A patent/AU2019388016B2/en active Active
- 2019-11-29 EP EP19891644.7A patent/EP3888751B1/en active Active
- 2019-11-29 CN CN201980078419.XA patent/CN113195054A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7473207B2 (ja) | 2024-04-23 |
| EP3888751B1 (en) | 2024-04-17 |
| US12611430B2 (en) | 2026-04-28 |
| WO2020111249A1 (ja) | 2020-06-04 |
| EP3888751C0 (en) | 2024-04-17 |
| EP3888751A4 (en) | 2022-10-05 |
| KR20210099014A (ko) | 2021-08-11 |
| AU2019388016A1 (en) | 2021-07-08 |
| SG11202105686UA (en) | 2021-06-29 |
| CN113195054A (zh) | 2021-07-30 |
| US20220000936A1 (en) | 2022-01-06 |
| EP3888751A1 (en) | 2021-10-06 |
| AU2019388016B2 (en) | 2024-12-19 |
| KR102901451B1 (ko) | 2025-12-16 |
| JPWO2020111249A1 (https=) | 2020-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101730052B1 (ko) | 심근경색의 수복 재생을 유도하는 다능성 간세포 | |
| JP5606008B2 (ja) | 骨髄間質細胞及び間葉系幹細胞の培養方法、中枢神経系疾患治療用の移植細胞の製造方法 | |
| KR102136450B1 (ko) | 당뇨병성 피부 궤양 치료를 위한 다능성 줄기 세포 | |
| EP3492091B1 (en) | "muse" cells as prophylactic or therapeutic agent for aneurysm | |
| JP5845089B2 (ja) | 肢虚血の治療 | |
| AU2019388016B2 (en) | Therapeutic agent of peripheral blood flow disorder | |
| US12599631B2 (en) | Agent for treating or preventing vascular dementia | |
| JP2025123077A (ja) | 脊髄梗塞治療のための多能性幹細胞 | |
| EP4026551A1 (en) | Therapeutic agent for myocarditis | |
| KR20230137808A (ko) | 지방 조직 유래 중간엽 줄기세포 및 인간 기질 혈관 분획을 포함하는 혈관신생 촉진용 조성물 | |
| Dai Matsuse et al. | Human Umbilical CordYDerived Mesenchymal Stromal Cells Differentiate Into Functional Schwann Cells That Sustain Peripheral Nerve Regeneration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20231025 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241104 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241104 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241104 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20241206 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250403 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250407 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250408 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250408 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251020 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251020 |